New pill could help dialysis patients control dangerous phosphate levels
Disease control
Recruiting now
This study tests a new drug called AP306 in 168 adults on maintenance hemodialysis who have high phosphate levels (hyperphosphatemia). Participants take one of several fixed doses of AP306 or a placebo daily for 8 weeks. The main goal is to see if AP306 safely lowers blood phosph…
Phase: PHASE2 • Sponsor: R1 Therapeutics • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC